Matches in SemOpenAlex for { <https://semopenalex.org/work/W2128490622> ?p ?o ?g. }
- W2128490622 endingPage "497" @default.
- W2128490622 startingPage "485" @default.
- W2128490622 abstract "Production of biochemically defined recombinant mistletoe lectin was achieved by cloning and separate expression of the single catalytically active A-chain and the B-chain with carbohydrate binding properties in Escherichia coli, yielding an active heterodimeric protein named rViscumin (Eck et al. [1999] Eur. J. Biochem., 265, 788-797). Employing solid phase binding assays, rViscumin was shown to preferentially bind to terminally alpha2-6-sialylated neolacto-series gangliosides IV(6)Neu5Ac-nLc4Cer, VI(6)Neu5Ac-nLc6Cer, and VIII(6)Neu5Ac-nLc8Cer isolated from human granulocytes. Only marginal binding of rViscumin to galactose-terminated neutral GSLs was determined, whereas reinvestigation of ricin specificity demonstrated this lectin as a galactose-binding protein. Human promyelotic HL-60 cells exhibited an IC(50) value (half maximum cytotoxicity) of 1.16 pM and human bladder carcinoma 5637 cells of 12.1 pM rViscumin; CHO-K1 cells were resistant to rViscumin treatment up to a concentration of 5.26 nM tested. Quantification of the predominant receptor ganglioside IV(6)Neu5Ac-nLc4Cer by means of a specific anti-Neu5Acalpha2-6Galbeta1-4GlcNAc-R antibody revealed 3.68 x 10(6) and 1.54 x 10(6) receptor molecules per HL-60 and 5637 cell, respectively; CHO-K1 cells were negative, lacking alpha2-6-sialylated gangliosides. The data imply a direct correlation of rViscumin cytotoxicity and the expression of receptor ganglioside. Moreover, CHO-K1 cells were rendered susceptible toward rViscumin cytotoxicity after exogenous application of human granulocyte gangliosides. Thus, (1) rViscumin has to be considered as a sialic acid-specific rather than a galactose-specific type II ribosome-inactivating protein, and (2) neolacto-series gangliosides with Neu5Acalpha2-6Galbeta1-4GlcNAc-terminus are true functional and physiologically relevant rViscumin receptors." @default.
- W2128490622 created "2016-06-24" @default.
- W2128490622 creator A5018371604 @default.
- W2128490622 creator A5021481408 @default.
- W2128490622 creator A5040427315 @default.
- W2128490622 creator A5046935993 @default.
- W2128490622 creator A5055260011 @default.
- W2128490622 creator A5058710861 @default.
- W2128490622 creator A5064972553 @default.
- W2128490622 creator A5090308584 @default.
- W2128490622 creator A5091672700 @default.
- W2128490622 date "2002-08-01" @default.
- W2128490622 modified "2023-10-17" @default.
- W2128490622 title "Preferential binding of the anticancer drug rViscumin (recombinant mistletoe lectin) to terminally 2-6-sialylated neolacto-series gangliosides" @default.
- W2128490622 cites W1492012195 @default.
- W2128490622 cites W1510419033 @default.
- W2128490622 cites W1515525226 @default.
- W2128490622 cites W1517080149 @default.
- W2128490622 cites W1536299500 @default.
- W2128490622 cites W1580792258 @default.
- W2128490622 cites W1601227390 @default.
- W2128490622 cites W1754937767 @default.
- W2128490622 cites W187359374 @default.
- W2128490622 cites W1956725963 @default.
- W2128490622 cites W1971072963 @default.
- W2128490622 cites W1971832131 @default.
- W2128490622 cites W1982800335 @default.
- W2128490622 cites W1987044112 @default.
- W2128490622 cites W1990377796 @default.
- W2128490622 cites W1990659921 @default.
- W2128490622 cites W1992066825 @default.
- W2128490622 cites W1992260617 @default.
- W2128490622 cites W2009259680 @default.
- W2128490622 cites W2009923088 @default.
- W2128490622 cites W2011614361 @default.
- W2128490622 cites W2011785740 @default.
- W2128490622 cites W2020272832 @default.
- W2128490622 cites W2024896179 @default.
- W2128490622 cites W2030060796 @default.
- W2128490622 cites W2031280774 @default.
- W2128490622 cites W2034949869 @default.
- W2128490622 cites W2035242228 @default.
- W2128490622 cites W2039747916 @default.
- W2128490622 cites W2055133784 @default.
- W2128490622 cites W2055348484 @default.
- W2128490622 cites W2058403143 @default.
- W2128490622 cites W2061038952 @default.
- W2128490622 cites W2063046210 @default.
- W2128490622 cites W2065765005 @default.
- W2128490622 cites W2067448979 @default.
- W2128490622 cites W2067596671 @default.
- W2128490622 cites W2075354803 @default.
- W2128490622 cites W2075836148 @default.
- W2128490622 cites W2078108847 @default.
- W2128490622 cites W2078870929 @default.
- W2128490622 cites W2080693201 @default.
- W2128490622 cites W2091699055 @default.
- W2128490622 cites W2094274802 @default.
- W2128490622 cites W2104241705 @default.
- W2128490622 cites W2106657658 @default.
- W2128490622 cites W2134353518 @default.
- W2128490622 cites W2146455544 @default.
- W2128490622 cites W2147243525 @default.
- W2128490622 cites W2148440676 @default.
- W2128490622 cites W2150380845 @default.
- W2128490622 cites W2151260274 @default.
- W2128490622 cites W2154072387 @default.
- W2128490622 cites W2207393693 @default.
- W2128490622 cites W2210269088 @default.
- W2128490622 cites W2326448744 @default.
- W2128490622 cites W2399419977 @default.
- W2128490622 cites W2419334544 @default.
- W2128490622 doi "https://doi.org/10.1093/glycob/cwf062" @default.
- W2128490622 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12145189" @default.
- W2128490622 hasPublicationYear "2002" @default.
- W2128490622 type Work @default.
- W2128490622 sameAs 2128490622 @default.
- W2128490622 citedByCount "40" @default.
- W2128490622 countsByYear W21284906222012 @default.
- W2128490622 countsByYear W21284906222013 @default.
- W2128490622 countsByYear W21284906222014 @default.
- W2128490622 countsByYear W21284906222019 @default.
- W2128490622 countsByYear W21284906222020 @default.
- W2128490622 countsByYear W21284906222021 @default.
- W2128490622 countsByYear W21284906222022 @default.
- W2128490622 crossrefType "journal-article" @default.
- W2128490622 hasAuthorship W2128490622A5018371604 @default.
- W2128490622 hasAuthorship W2128490622A5021481408 @default.
- W2128490622 hasAuthorship W2128490622A5040427315 @default.
- W2128490622 hasAuthorship W2128490622A5046935993 @default.
- W2128490622 hasAuthorship W2128490622A5055260011 @default.
- W2128490622 hasAuthorship W2128490622A5058710861 @default.
- W2128490622 hasAuthorship W2128490622A5064972553 @default.
- W2128490622 hasAuthorship W2128490622A5090308584 @default.
- W2128490622 hasAuthorship W2128490622A5091672700 @default.
- W2128490622 hasBestOaLocation W21284906221 @default.
- W2128490622 hasConcept C104317684 @default.
- W2128490622 hasConcept C108625454 @default.